Connect with us
The U.S. saw a proper drop in deaths as COVID-19's impact that still seem less, but other causes like unintentional injuries and chronic diseases remain significant...
US FDA Approves Novartis’ Fabhalta for IgA Nephropathy, Showing 44% Reduction in Urine Protein Levels.
The FDA's approval of the Shield blood test gives a new screening option for the colon cancer, but it still needs to follow-up colonoscopies to confirm...